BROOKE REISING: Open Payments
NPI 1699493320 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 87 payments from 16 companies in 2025. Trend: 2023 $476 · 2024 $720 · 2025 $1,754
Food & beverage: $1,645Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $347 |
| Novartis Pharmaceuticals Corporation | 16 | $328 |
| Galderma Laboratories, L.P. | 7 | $217 |
| Lilly USA, LLC | 8 | $174 |
| Janssen Biotech, Inc. | 3 | $155 |
| Arcutis Biotherapeutics, Inc. | 8 | $154 |
| UCB, Inc. | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $65 |
| Incyte Corporation | 2 | $58 |
| GENZYME CORPORATION | 2 | $43 |
Products named: SKYRIZI, NEMLUVIO, COSENTYX, EBGLYSS, TREMFYA, Zoryve, RINVOQ, Bimzelx.
Industry payments across IN — which companies pay providers there.
